Curi RMB Capital’s ResMed RMD Stock Holding History

Curi RMB Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-793	Closed	-$207K	–	456
2021 Q4	$207K	Buy	+793	New	+$206K	0.01%	443

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Curi RMB Capital's RMD Position: Q1 2022 in Review

Curi RMB Capital sold out of ResMed (RMD) in Q1 2022, closing a stake of 793 shares — an estimated $207K sold.

Curi RMB Capital first reported a position in RMD in Q4 2021 and held it in 1 quarter. The position peaked at $207K in Q4 2021. 682 funds tracked by Wall St. Rank hold RMD as of Q1 2022.

Curi RMB Capital reported no remaining ResMed position as of Q1 2022 after selling out during the quarter.
Curi RMB Capital sold 793 ResMed shares in Q1 2022, an estimated $207K.
Curi RMB Capital first reported a position in ResMed in Q4 2021 and held it in 1 quarter.
Curi RMB Capital's ResMed position peaked at $207K in Q4 2021.
682 funds tracked by Wall St. Rank held ResMed as of Q1 2022.

Based on Curi RMB Capital's 13F filing for Q1 2022, filed 6 May 2022.